National Survey of Chronic Heart Failure in Argentina. Variables in Relation to In-Hospital Mortality Rate (Preliminary Results CONAREC VI)
pp 53-62
DOI:
https://doi.org/10.7775/rac.v67i1.3270Keywords:
Heart failure , Prognosis , MortalityAbstract
Methods
Between December 1996 through October 1997, 31 argentine hospital centers participated in a national survey about chronic congestive heart failure (CHF)(> 30 days evolution), to identify variables in relation to in-hospital mortality rate.
Results
During the time of the study, 751 patients were evaluated (mean age 65.5 years, 41% were males). Previous medication (before admission): digital 48%, ACE 58%, diuretics 59%. Only 21.5% were employed, and the New York Heart Association (NYHA) functional class were I-II in 70%. In only 57% of the patients the cause of decompensation was known, and in 20% of it was sudden. At the time of hospitalization 89% were in NYHA III-IV. The etiology of the CHF was coronary artery disease in 30%, hipertensive cardiomyopathy in 21%,valvular heart disease in 17%, idiopathic cardiomyopathy in 14%, and others in the left 18% of patients. The mortality rate was 4.6%. The variables associated with death in the univariate analysis were the habitual NYHA class (p = 0.01), global heart failure (p = 0.005), low systolic (p = 0.003) and diastolic (p = 0.007) blood pressure at the time of admission, hyponatremia (p = 0.02), peripheral hypoperfusion (p = 0.02) and hepatojugular reflux(p = 0.045). In the multivariate analysis were independent variables, NYHA class III-IV before the hospitalization (OR = 3.27, p = 0.038) global heart failure (OR = 11.04, p = 0.023) and hyponatremia (OR 1.14, p = 0.008), length of the illness (OR = 1.02,p = 0.027).
Conclusion
The associated features with in-hospital death rates were preadmission functional class, length of the disease, biventricular heart failure, hyponatremia.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Argentine Journal of Cardiology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.







